Pharmaresearch Joins Hands with China's CCM to Accelerate Local Market Expansion

Maximizing Synergy Through Joint Venture

"Broad Cooperation Including Local Product Development"

Pharmaresearch announced on September 21 that it has signed a strategic Memorandum of Understanding (MOU) for cooperation with Chinese cosmetics company CCM to expand Rejuran Cosmetic's presence in the Chinese market.

Founded in 2002, CCM is an investment-driven cosmetics brand management company in China, owning multiple brands that enjoy high recognition both domestically and internationally. Last year, CCM posted sales of about 9.178 billion yuan (approximately 1.9 trillion won), ranking second in sales among Chinese cosmetics groups.

Pharmaresearch and CCM officials are taking a commemorative photo after signing a business agreement. Pharmaresearch

The two companies plan to maximize their synergy by establishing a joint venture (JV) in the future. Pharmaresearch aims to expand its cooperation beyond supplying finished Rejuran Cosmetic products to also include developing localized products and utilizing the Rejuran Cosmetic brand.

A Pharmaresearch representative said, "In the United States, we are strengthening our local production base by acquiring cosmetics contract development and manufacturing organization (CDMO) company CG USA. In China, we plan to accelerate commercialization by partnering with CCM, which has expertise in product research and development (R&D), brand building, and business operations."

This content was produced with the assistance of AI translation services.